SignaBlok to Present Novel Approach to Preventing Pancreatic Cancer Recurrence at the 2026 AACR Annual Meeting
Timely resolution of inflammation induced by standard-of-care cancer treatments can be a common approach to prevent cancer recurrence in multiple cancer types SHREWSBURY, MA, UNITED STATES, March 26, 2026 /EINPresswire.com/ -- SignaBlok, Inc.. a …